Experimental myotonia and hypocholesterolemic agents.
D000251:Adenosine Triphosphatases / Q000378:metabolism; D000818:Animals; D000924:Anticholesteremic Agents / Q000009:adverse effects* / Q000494:pharmacology; D002462:Cell Membrane / Q000187:drug effects / Q000201:enzymology; D002784:Cholesterol / Q000031:analogs & derivatives / Q000378:metabolism; D004576:Electromyography; D004912:Erythrocytes / Q000187:drug effects / Q000201:enzymology; D008297:Male; D009132:Muscles / Q000187:drug effects / Q000378:metabolism; D009222:Myotonia / Q000139:chemically induced* / Q000378:metabolism; D051381:Rats; D013261:Sterols / Q000378:metabolism; D014308:Triparanol / Q000494:pharmacology; D001371:trans-1,4-Bis(2-chlorobenzaminomethyl)cyclohexane Dihydrochloride / Q000494:pharmacology
D000924:Anticholesteremic Agents; D013261:Sterols; D001371:trans-1,4-Bis(2-chlorobenzaminomethyl)cyclohexane Dihydrochloride; D014308:Triparanol; D002784:Cholesterol; D000251:Adenosine Triphosphatases